马歇尔静脉中的乙醇输液用于持续性心房移除:随机对照试验的证据
Carolina Saleiro1, Sérgio Barra2, Bárbara Oliveiros3
1Pacing & Electrophysiology Unit, Cardiology Department, Coimbra's Hospital and University Center, Coimbra, Portugal.
Journal of cardiovascular electrophysiology
|September 3, 2025
概括
乙醇输入马歇尔静脉 (VoM) 提高了持续性心房动 (AF) 的导管切除 (CA) 的成功率. 这种方法可以改善心律失常,而不会增加严重并发症的风险,支持其在肌肉动脉治疗中使用.
科学领域:
- 心脏病学
- 电生理学
- 医疗干预
背景情况:
- 肺静脉隔离 (PVI) 是心房的主要治疗方法,但在持续性心房的病例中,其有效性有限.
- 马歇尔静脉 (VoM) 是一个胚胎遗留物,与AF的发病有关,可能是改善切除结果的目标.
研究的目的:
- 评估乙醇输入VoM的有效性,作为持续性AF患者的导管切除 (CA) 的辅助.
主要方法:
- 对随机对照试验 (RCT) 进行了系统审查和元分析.
- 这项研究将CA与VoM乙醇输注进行比较,用于持续性AF的首次切除手术.
- 主要结论是12个月的随访期内没有心房律乱的发生率.
主要成果:
- 这项分析包括四项与1045名患者进行的RCT,535名患者接受了VoM乙醇输液加CA,而510名患者仅接受CA.
- VoM 乙醇输注显著增加了心房失常的发生率 (RR 1. 21),并减少了重复手术的需要 (RR 0. 63).
- 在VoM输液中,心脏静脉阻塞更频繁 (RR 1. 30),主要并发症没有显著差异,但整体并发症较高.
结论:
- 将乙醇输入马歇尔静脉,以进行导管切除,可改善持续性肌动力障碍患者的心律失常.
- 这种辅助疗法不会增加严重并发症的风险.
- VoM 乙醇输液在持续性 AF 的导管切除策略中表现有前途.
相关概念视频
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Dysrhythmias VI: Management of Dysrhythmias
106
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
106
Cardiopulmonary Resuscitation IV: Pharmacological Management
75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
Varicose Veins II: Diagnostic Studies and Interprofessional Care
31
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
31


